-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

636.O1.6 636. Myelodysplastic Syndromes – Basic and Translational: Molecular Drivers and Therapeutic Implications

Symposia: Myelodysplastic Syndromes—Basic and Translational Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Translational Research, hematopoiesis, metabolism, Biological Processes
Saturday, December 9, 2023: 4:00 PM-5:30 PM
Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego Marina)
Moderators:
Robert Welner, PhD, Beth Israel Deaconess Medical Center and Zuzana Tothova, MD, PhD, Dana-Farber Cancer Institute
Disclosures:
No relevant conflicts of interest to declare.
4:00 PM

Martina Sarchi, MD, PhD1,2*, Courtnee A. Clough, PhD1,3, Edie I. Crosse, PhD4,5*, Jason Kim1*, Laura D. Baquero Galvis1,3, Anna Gallì6*, J. Philip Creamer, PhD1*, Sintra Stewart1*, Sara Pozzi2*, Elisabetta Molteni, PhD6*, Chiara Elena, MD6*, Robert K. Bradley, PhD4,5,7, Luca Malcovati, MD6,8 and Sergei Doulatov, PhD1,7,9

1Division of Hematology, Department of Medicine, University of Washington, Seattle, WA
2Department of Molecular Medicine, University of Pavia, Pavia, Italy
3Molecular and Cellular Biology Program, University of Washington, Seattle
4Computational Biology Program, Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA
5Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA
6Department of Hematology, IRCCS S. Matteo Hospital Foundation, Pavia, Italy
7Department of Genome Sciences, University of Washington, Seattle, WA
8Department of Molecular Medicine, University of Pavia, Piazzale Golgi 2, Italy
9Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA

4:15 PM

Noah A Salama1*, Emily R Quarato, MS1*, Olivia Lynch, BA, MPH1*, Yuko Kawano, MD, PhD2*, Chen Yu, MS1*, Benjamin Rodems, MS3*, Eric Cefaloni1*, Marlies P. Rossmann, MD, PhD4, Paula Vertino, PhD, BS1*, Laurie A. Steiner, MD5, Kathleen E. McGrath, PhD1, James Palis, MD1, Roman Eliseev, MD/PhD1*, Jane L. Liesveld, MD6, Jeevisha Bajaj, PhD2 and Laura Calvi, MD1

1University of Rochester, Rochester, NY
2University of Rochester Medical Center, Rochester, NY
3University of Rochester Medical Center, Rochester
4Department of Biomedical Genetics, University of Rochester School of Medicine and Dentistry, Rochester, NY
5Center for Pediatric Biomedical Research, Department of Pediatrics, University of Rochester Medical Center, Rochester, NY
6James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY

4:30 PM

Daniel Chang, BSc1*, Klara E Noble-Orcutt, BS, MS2*, Wendy Hudson1*, Aishwarya Iyer, BSc, MSc3*, Emily Pomeroy, MS1*, Craig E. Eckfeldt, MD, PhD4, Aaron Sarver, PhD1*, Nuri Alpay Temiz, PhD1*, Michael Linden, MD, PhD4, Chad L Myers, PhD5,6*, David A. Largaespada, PhD1* and Zohar Sachs, MD, PhD2,7

1University of Minnesota, Minneapolis, MN
2Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
3University of Alberta, Edmonton, AB, CAN
4University of Minnesota Medical School, Minneapolis, MN
5Department of Computer Science and Engineering, University of Minnesota, Minneapolis, MN
6Bioinformatics and Computational Biology Program, University of Minnesota, Minneapolis, MN
7Masonic Cancer Center, University of Minnesota, Minneapolis, MN

4:45 PM

Carmelo Gurnari, MD1,2, Hideki Makishima, MD, PhD3, Arda Durmaz1*, Ryunosuke Saiki3*, Guilherme Mendes Sapinho4,5*, Alex Bataller, MD, PhD6*, Lukasz P. Gondek, MD, PhD7, Yasuhito Nannya3*, Steve Best4*, Pramila Krishnamurthy4*, Hussein Awada1*, Enrico Attardi, MD2*, Valeria Visconte, PhD1*, Maria Teresa Voso, MD2, Amy E. DeZern, MD, MHS8, Guillermo Garcia-Manero, MD6, Austin Kulasekararaj, MD, MBBS, FRCPath, MRCP9, Jaroslaw P. Maciejewski, M.D., Ph.D., FACP1 and Seishi Ogawa10

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
3Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
4Department of Haematological Medicine, King's College Hospital NHS, London, United Kingdom
5Serviço de Hematologia e Transplantação de Medula, Centro Hospitalar Lisboa Norte, Lisbon, Portugal
6The University of Texas MD Anderson Cancer Center, Houston, TX
7Sidney Kimmel Comprehensive Cancer Center, Department of Oncology, Johns Hopkins University, Baltimore, MD
8Johns Hopkins University, Baltimore, MD
9Department of Haematological Medicine, King's College Hospital, London, United Kingdom
10Department of Pathology and Tumor Biology, Kyoto University Graduate School of Medicine, Sakyoku, KYO, Japan

5:00 PM

He Tian (Tony) Tony Chen, BSc1,2, Pratik Joshi, BSc3,4*, Emily Tsao, BSc3,4, Joshua Xu, BSc5, Soheil Jahangiri, PhD4*, Yulin Mo, MSc2*, David Kealy, PhD6*, Dylan Gowlett-Park7,8*, Katarina Czibere, BSc7,8*, Alexandra Misura, BSc7,8*, Olga Bigun, MD7,8*, Renato Sasso7,8*, Dianne Chadwick, PhD8,9*, Sila Usta, BSc7,8*, Tina Khazaee, MEng, MSc7,8*, Signy Chow, MD10,11, Hubert Tsui, MD, PhD, FRCPC7,8,12,13, Mark D. Minden3,4*, Katherine S Bridge, PhD, BSc6*, Gang Zheng, PhD2,3* and Kristin J. Hope3,4

1Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada
2University Health Network, Toronto, ON, Canada
3Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada
4Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
5Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, CAN
6Department of Biology, University of York, York, GBR
7Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
8Precision Diagnostics and Therapeutics Program, Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
9Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, Toronto, Canada
10Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
11Temerty Faculty of Medicine, University of Toronto, Toronto, ON, CAN
12Department of Immunology, University of Toronto, Toronto, Canada
13Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada

5:15 PM

Srinivas Aluri, PhD1*, Ellen Fraint1, Samarpana Chakraborty1, Aarif Ahsan2*, Gowri Poigailwar1*, Rongbao Zhao, PhD3*, Kith Pradhan, PhD3*, Kimo Bachiashvili1, Anjali Budhathoki1*, Beamon Agarwal4*, Shanisha Gordon Mitchell3*, Milagros Carbajal1*, Srabani Sahu3*, Jacqueline Boultwood, PhD5*, Andrea Pellagatti6*, Ulrich Steidl, MD, PhD1, Amittha Wickrema7*, Satish Nandakumar1, Aditi Shastri, MD1, Teresa Bowman1, Sadanand Vodala8 and Amit K. Verma, MD1

1Department of Oncology, Albert Einstein College of Medicine, New York, NY
2Formerly Translational Medicine, Bristol Myers Squibb, Summit, NJ
3Montefiore Einstein Cancer Center, Blood Cancer Institute, Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
4GenomeRx, Barrington, IL
5Bloodwise Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom
6University of Oxford, Oxford, United Kingdom
7University of Chicago, Chicago, IL
8Hematology, Translational Medicine and Disease Team, Bristol Myers Squibb, Summit, NJ

*signifies non-member of ASH